8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



        Date of Report (Date of earliest event reported): August 14, 2006


                        Blonder Tongue Laboratories, Inc.
             (Exact Name of registrant as specified in its charter)



           Delaware                     1-14120                52-1611421
(State or other jurisdiction  (Commission File Number)    (I.R.S. Employer
        of incorporation)                                  Identification No.)


                One Jake Brown Road, Old Bridge, New Jersey 08857
               (Address of principal executive offices) (Zip Code)



       Registrant's telephone number, including area code: (732) 679-4000


                                 Not Applicable
          (Former name or former address, if changed since last report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:


[_]  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)


[_]  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)


[_]  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d-2(b))


[_]  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e-4(c))






Item 2.02.  Results of Operations and Financial Condition

On August 14, 2006,  Blonder Tongue  Laboratories,  Inc.  issued a press release
announcing its unaudited financial results for the second quarter ended June 30,
2006. A copy of the press release is attached to this Report as Exhibit 99.1 and
is incorporated herein by reference.  The information  disclosed in this report,
including  Exhibit  99.1  hereto,  is being  furnished  and  shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934.

Item 9.01.  Financial Statements and Exhibits

(a)      Not applicable


(b)      Not applicable


(c)      Not applicable


(d)      The following exhibits are filed herewith:


     Exhibit 99.1 Press Release dated August 14, 2006.





                                       2





                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                    BLONDER TONGUE LABORATORIES, INC.



                                    By:/s/ Eric Skolnik                                         
                                         Eric Skolnik
                                         Senior Vice President
                                         and Chief Financial Officer

Date: August 14, 2006






                                       3







                                  EXHIBIT INDEX


         Exhibit No.               Description

         Exhibit 99.1    Press Release of Blonder Tongue Laboratories, Inc.
                         dated August 14, 2006 regarding its unaudited financial
                         results for the second quarter ended June 30, 2006.

EX-99

                                                                    EXHIBIT 99.1


[LOGO]                                                       One Jake Brown Road
                                                                   P.O. Box 1000
                                               Old Bridge, New Jersey 08857-1000
                                           Tel: 732-679-4000   Fax: 732-679-4353


FOR IMMEDIATE RELEASE                         CONTACT:   James A. Luksch
                                                         Chairman and
                                                         Chief Executive Officer
                                                         (732) 679-4000






               BLONDER TONGUE REPORTS 2006 SECOND QUARTER RESULTS

OLD BRIDGE,  NEW JERSEY,  August 14, 2006 - Blonder  Tongue  Laboratories,  Inc.
(AMEX:  "BDR") today  reported net sales of  $10,012,000  for the second quarter
2006, a 6.4 percent increase over net sales of $9,408,000 reported in the second
quarter 2005. The additional sales are attributed to an overall increase in core
headend,  distribution  and fiber  equipment  as well as an increase in digital,
high  definition  and  interdiction  product  sales.  Sales of digital  and high
definition  products were  $1,323,000 and  $1,108,000 and sales of  interdiction
products  were  $650,000  and  $500,000 in the second  quarter of 2006 and 2005,
respectively.

Net loss for the  second  quarter  2006 was  $404,000,  or  ($0.05)  per  share,
compared  to a net loss of  $641,000  or  ($0.08)  per share for the  comparable
period in 2005. Net loss for the six months ended June 30, 2006 was $212,000, or
($0.03) per share, compared to a net loss of $1,531,000 or ($0.19) per share for
the comparable period in 2005.

Commenting on the second quarter 2006 results,  James A. Luksch, Chief Executive
Officer,   said,  "The  comparable   quarter-to-quarter   sales  improvement  is
indicative  of the continued  long term progress of our new product  offerings."
Mr. Luksch  continued,  "We are addressing the  disappointing  earnings through,
among other things,  the  elimination  of certain  non-core  business units that
adversely affect our financial performance. We recently disposed of our interest
in Blonder  Tongue  Telephone  and, as reported in the last several  days,  have
announced our intention to divest BDR Broadband,  our Texas-based  private cable
system.  We anticipate that the divesture of these two businesses  should result
in approximately a $600,000 improvement to our net income on an annual basis."

Founded  in  1950,  Blonder  Tongue  Laboratories,   Inc.  has  evolved  from  a
manufacturer  of  electronic  equipment  for the  private  cable  industry  to a
principal  provider of integrated  network  solutions and technical  services to
broadband service providers. The Company designs,  manufactures,  and supplies a
comprehensive line of equipment to deliver video (analog & digital),  high speed
data and voice  services  over  integrated  coaxial  and fiber  optic  broadband
networks today and over packet based,  Internet protocol networks of the future.
For more information regarding Blonder Tongue or its products,  please visit the
Company's Web site at  www.blondertongue.com  or contact the Company directly at
(732) 679-4000.

"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995: The information set forth above includes "forward-looking"  statements and
accordingly,  the cautionary  statements  contained in Blonder  Tongue's  Annual
Report and Form 10-K for the year ended December 31, 2005 (See Item 1: Business,
Item 1A:  Risk  Factors  and Item 7:  Management's  Discussion  and  Analysis of
Financial  Condition  and Results of  Operations),  and other  filings  with the
Securities and Exchange  Commission are  incorporated  herein by reference.  The
words  "believe",  "expect",  "anticipate",  "should",  "project",  and  similar
expressions identify  forward-looking  statements.  Readers are cautioned not to
place  undue  reliance  on  these  forward-looking  statements,   which  reflect
management's  analysis only as of the date hereof.  Blonder Tongue undertakes no
obligation to publicly revise these forward-looking statements to reflect events
or  circumstances  that arise after the date  hereof.  There can be no assurance
that Blonder  Tongue will be  successful  in its efforts to sell BDR  Broadband.
Blonder Tongue's actual results may differ from the anticipated results or other
expectations expressed in Blonder Tongue's "forward-looking" statements.

                                     -MORE-





                        Blonder Tongue Laboratories, Inc.
                    Consolidated Summary of Operating Results
                      (in thousands, except per-share data)
                                   (unaudited)


                                 Three months ended             Six months ended
                                      June 30,                      June 30,
                                 -----------------------------------------------
                                   2006        2005          2006       2005

Net sales                        $10,012     $9,408       $20,399    $18,677
Gross profit                       3,347      2,859         6,917      5,386
Earnings (loss) from operations     (170)      (341)          267       (944)
Net earnings (loss)                 (404)      (641)         (212)    (1,531)
Net earnings (loss) per share:
   Basic                          $(0.05)    $(0.08)       $(0.03)    $(0.19)
   Diluted                        $(0.05)    $(0.08)       $(0.03)    $(0.19)

FOR IMMEDIATE RELEASE
 outstanding:
   Basic                           8,010      8,015         8,013      8,015
   Diluted                         8,010      8,015         8,013      8,015






                       Consolidated Summary Balance Sheets
                                 (in thousands)


                                             June 30, 2006     December 31, 2005
                                              (unaudited)

Current assets                                   $15,076              $15,144
Property, plant, and equipment, net                5,965                6,184
Total assets                                      31,291               32,864
Current liabilities                                7,613                8,036
Long-term liabilities                              3,193                3,329
Stockholders' equity                              20,485               21,499

Total liabilities and stockholders'
 equity                                          $31,291              $32,864




                                       2